Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375659 · ClinicalTrials.gov registry record
Black Patients' Lived Experiences and Perceptions of Skin of Color Clinics
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 19
- Enrollment target
NCT02375659: Completed study, sponsored by Northwestern University.
NCT02375659 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02375659 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Across the U.S. Skin of Color (SOC) clinics have been established with the goal of providing medical care and supporting research related to patients with skin of color. There have been no formal studies evaluating why patients seek medical care at SOC clinics or treatment outcomes. Reasons may include past experiences with other providers, the perception that providers working in these clinics have a special interest or knowledge in caring for patients with skin of color and thus may provide better care, the expectation of cultural sensitivity, the hope that their provider may have a similar ethnic background, and/or ease of communication with their provider. Through focus group discussions we aim to identify the factors influencing a patient's choice to seek medical care at a SOC clinic and to gain insight into the presence and impact of racial concordance between provider and patient. The current study will focus on self-identified African American patients with interest in conducting similar sessions with patients of other ethnicities and races in the future.
Primary Outcome
Audiotapes of focus group discussions will be transcribed, and the transcripts will be analyzed via a 'long-hand' inductive approach by two dermatologists and one psychologist. For each of the 8 posed focus group questions, the reviewers will independently induce a common thematic response. Collectively, they will then compare their independently derived themes, identifying themes of agreement and disagreement. Areas of disagreement will be further reviewed until a mutually agreed upon final set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-09 |
What the finished NCT02375659 record still lists
NCT02375659 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02375659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02375659 about?
NCT02375659 is a clinical study titled "Black Patients' Lived Experiences and Perceptions of Skin of Color Clinics". Across the U.S. Skin of Color (SOC) clinics have been established with the goal of providing medical care and supporting research related to patients with skin of color. There have been no formal studies evaluating why patients seek medical care at SOC clinics or treatment outcomes. Reasons may incl...
What is the current status of trial NCT02375659?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2015-02. Estimated completion is 2017-09.
Who is sponsoring clinical trial NCT02375659?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia